This funding opportunity, issued by the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services, aims to support data mining of single cell datasets to identify cell types, transcripts, enhancers, or transcriptional networks involved in HIV/antiretroviral therapy (ART) or Substance Use Disorder (SUD)-related molecular responses. Additionally, it will fund functional validation studies, such as epigenomic or transcriptomic manipulation and high throughput secondary screening, to establish the biological role of the identified targets in these contexts. Clinical trials are not allowed under this R21 initiative. The funding instrument is a discretionary grant supporting projects in the areas of education and health.
This funding opportunity, issued by the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services, aims to support data mining of single cell datasets to identify cell types, transcripts, enhancers, or transcriptional networks involved in HIV/antiretroviral therapy (ART) or Substance Use Disorder (SUD)-related molecular responses. Additionally, it will fund functional validation studies, such as epigenomic or transcriptomic manipulation and high throughput secondary screening, to establish the biological role of the identified targets in these contexts. Clinical trials are not allowed under this R21 initiative. The funding instrument is a discretionary grant supporting projects in the areas of education and health.